Basel III Regulatory Capital Disclosures
Basel III Regulatory Capital DisclosuresSeptember 30, 2021
Table of ContentsIntroduction1Overview1Current Regulatory Environment and Other Developments1Disclosure Matrix3Components of Capital10Capital Adequacy – Standardized Risk-Weighted Assets10Capital Adequacy – Capital Ratios11Credit Risk11Securitizations13Equities not Subject to the Market Risk Capital Rule15Supplementary Leverage Ratio15
INTRODUCTIONThe Charles Schwab Corporation (CSC) is a savings and loan holding company (SLHC) engaged, through its subsidiaries(collectively referred to as Schwab or the Company), in wealth management, securities brokerage, banking, asset management,custody, and financial advisory services.Principal business subsidiaries of CSC include the following: Charles Schwab & Co., Inc. (CS&Co), incorporated in 1971, a securities broker-dealer;TD Ameritrade, Inc., an introducing securities broker-dealer;TD Ameritrade Clearing, Inc. (TDAC), a securities broker-dealer that provides trade execution and clearing services toTD Ameritrade, Inc.;Charles Schwab Bank, SSB (Schwab Bank), Schwab’s principal banking entity; andCharles Schwab Investment Management, Inc. (CSIM), the investment advisor for Schwab’s proprietary mutual funds(Schwab Funds ), and Schwab’s exchange-traded funds (Schwab ETFsTM).Schwab provides financial services to individuals and institutional clients through two segments – Investor Services andAdvisor Services.Effective October 6, 2020, the Company completed its acquisition of TD Ameritrade Holding Corporation (TDA Holding) and itsconsolidated subsidiaries (collectively referred to as “TD Ameritrade” or “TDA”). TD Ameritrade provides securities brokerageservices, including trade execution, clearing services, and margin lending, through its broker-dealer subsidiaries; and futures andforeign exchange trade execution services through its futures commission merchant (FCM) and forex dealer member (FDM)subsidiary.The basis of consolidation that CSC uses for regulatory reporting is consistent with the basis used for reporting under generallyaccepted accounting principles in the U.S. (U.S. GAAP) as established by the Financial Accounting Standards Board.OVERVIEWThis document, and certain of Schwab’s public filings, present the regulatory capital disclosures in compliance with Basel III asset forth in 12 C.F.R. §217.63 - Disclosures by institutions regulated by the Federal Reserve Board (“Federal Reserve”) and 12C.F.R. § 217.173 (c) (collectively referred to as the Rules). Schwab’s Annual Report on Form 10-K for the fiscal year endedDecember 31, 2020 (Form 10-K) filed with the Securities and Exchange Commission (SEC) and it’s Quarterly Report on Form10-Q for the quarterly period ended September 30, 2021 (Form 10-Q) filed with the SEC contain management’s discussion of theoverall corporate risk profile of Schwab and related management strategies. These Basel III Regulatory Capital Disclosures shouldbe read in conjunction with the Form 10-K, Form 10-Q, the Consolidated Financial Statements for Bank Holding Companiesdated September 30, 2021 (FR Y-9C), the Regulatory Capital Reporting for Institutions Subject to the Advanced CapitalAdequacy Framework dated September 30, 2021 (FFIEC 101) and the Consolidated Reports of Condition and Income for a Bankwith Domestic and Foreign Offices for the period ended September 30, 2021 (FFIEC 031). Schwab’s Disclosure Matrix (seepages 3-9) specifies where the disclosures required by the Rules are located.CURRENT REGULATORY ENVIRONMENT AND OTHER DEVELOPMENTSIn October 2019, the Federal Reserve, Office of the Comptroller of the Currency, and Federal Deposit Insurance Corporationjointly adopted a final rule which became effective on December 31, 2019 (interagency regulatory capital and liquidity rules) thatrevised the regulatory capital and liquidity requirements for large U.S. banking organizations with 100 billion or more in totalconsolidated assets. The rules established four risk-based categories for determining the regulatory capital and liquidityrequirements applicable to these institutions based on their total assets, cross-jurisdictional activity, weighted short-term wholesalefunding, nonbank assets, and off-balance sheet exposure. CSC is subject to the requirements under Category III based on its totalconsolidated assets of between 250 billion and less than 700 billion and having less than 75 billion in cross-jurisdictionalactivity.Capital requirements for Category III banking organizations include the generally applicable risk-based capital and Tier 1 leverageratio requirements (the “standardized approach” framework), the minimum 3.0% supplementary leverage ratio, thecountercyclical capital buffer which is currently 0%, and for large bank holding companies, the stress capital buffer. Under the1
revised capital requirements, Category III organizations are not subject to the “advanced approaches” regulatory capitalframework and are permitted to opt out of including accumulated other comprehensive income (AOCI) in their regulatory capitalcalculations. CSC made this opt out election, and commencing with the first quarter of 2020, now excludes AOCI from itsregulatory capital.On March 16, 2021, CSC’s declaration electing to be treated as a Financial Holding Company (FHC) was deemed effective by theFederal Reserve. In addition to the activities that savings and loan holding companies that have not elected to be treated as an FHCare permitted to conduct, the Company may now also engage in activities that are financial in nature or incidental to a financialactivity (FHC Activities), including securities underwriting, dealing and making markets in securities, various insuranceunderwriting activities, and making merchant banking investments in non-financial companies.Beginning in 2022, CSC, as a large SLHC will be subject to an annual Comprehensive Capital Analysis and Review (CCAR)process, which requires submission of an annual capital plan to the Federal Reserve. The process also imposes a stress capitalbuffer requirement, floored at 2.5 percent of risk-weighted assets, that will replace CSC’s current 2.5 percent capital conservationbuffer. The capital plan requirement will become effective for CSC with the 2022 CCAR cycle, and CSC’s initial stress capitalbuffer requirement will be based on its 2022 CCAR stress testing results.Following are links to the referenced public filings:Filing2020 Form 10-KSeptember 30, 2021 Form 10-QConsolidated Financial Statements forBank Holding Companies – FR Y-9Cdated September 30, 2021Regulatory Capital Reporting forInstitutions Subject to the AdvancedCapital Adequacy Framework – FFIEC101 dated September 30, 2021Consolidated Reports of Condition andIncome for a Bank with Domestic andForeign Offices – FFIEC 031 for thequarter ended September 30, 2021Consolidated Reports of Condition andIncome for a Bank with Domestic andForeign Offices – FFIEC 031 for thequarter ended September 30, 2021Consolidated Reports of Condition andIncome for a Bank with Domestic andForeign Offices – FFIEC 031 for thequarter ended September 30, 2021Link to itution/Profile/1026632?dt 20210316Note search terms below:Report Consolidated Financial Statements for BHCs (FR Y-9C)Report Date file/1026632?dt 20210316Note search terms below:Report Regulatory Capital Reporting for Institutions Subject to the AdvancedCapital Adequacy Framework (FFIEC 101)Report Date iles.aspxNote search terms below:Report CallReport Date 9/30/2021Institution Name Charles Schwab Bank, spxNote search terms below:Report CallReport Date 9/30/2021Institution Name Charles Schwab Premier Bank, spxNote search terms below:Report CallReport Date 9/30/2021Institution Name Charles Schwab Trust Bank2
DISCLOSURE MATRIXTableDisclosure RequirementScope of Application (Table 1)Qualitative:The name of the top corporate entity in the group to which(a)subpart D of this part applies.(b)(c)(d)(e)A brief description of the differences in the basis forconsolidating entities for accounting and regulatory purposes,with a description of those entities:(1) That are fully consolidated;(2) That are deconsolidated and deducted from total capital;(3) For which the total capital requirement is deducted; and(4) That are neither consolidated nor deducted (for example,where the investment in the entity is assigned a riskweight in accordance with this subpart).Any restrictions, or other major impediments, on transfer offunds or total capital within the group.The aggregate amount of surplus capital of insurancesubsidiaries included in the total capital of the consolidatedgroup.The aggregate amount by which actual total capital is lessthan the minimum total capital requirement in all subsidiaries,with total capital requirements and the name(s) of thesubsidiaries with such deficiencies.Capital Structure (Table 2)Qualitative:Summary information on the terms and conditions of the main(a)features of all regulatory capital instruments.Quantitative:(b)(c)(d)The amount of common equity tier 1 capital, with separatedisclosure of:(1) Common stock and related surplus;(2) Retained earnings;(3) Common equity minority interest;(4) Accumulated other comprehensive income (AOCI); and(5) Regulatory adjustments and deductions made tocommon equity tier 1 capital.The amount of tier 1 capital, with separate disclosure of:(1) Additional tier 1 capital elements, including additionaltier 1 capital instruments and tier 1 minority interest notincluded in common equity tier 1 capital; and(2) Regulatory adjustments and deductions made to tier 1capital.The amount of total capital, with separate disclosure of:(1) Tier 2 capital elements, including tier 2 capitalinstruments and total capital minority interest notincluded in tier 1 capital; and(2) Regulatory adjustments and deductions made to totalcapital.Disclosure LocationBasel III Regulatory Capital Disclosures:IntroductionBasel III Regulatory Capital Disclosures:IntroductionDisclosurePageSource Reference if applicablePg. 1Pg. 1Form 10-QPg. 19-21Pg. 60-61Form 10-QMD&A – Capital ManagementNote 17 – Regulatory RequirementsNot applicable. The Company does not haveany insurance subsidiaries.Not applicable. The Company does not haveany subsidiaries with total capital requirementswhere total capital is less than the minimumrequirement.Form 10-QPg. 19-21Pg. 27Pg. 55-56FR Y-9CPg. 51-53FFIEC 031Pg. 58-60Form 10-QMD&A – Capital ManagementConsolidated Balance SheetsNote 14 – Stockholders’ EquityFR Y-9CSchedule HC-R – Regulatory CapitalFFIEC 031Schedule RC-R – Regulatory CapitalBasel III Regulatory Capital Disclosures:Components of CapitalFR Y-9CSchedule HC-R – Regulatory CapitalFFIEC 031Schedule RC-R – Regulatory CapitalBasel III Regulatory Capital Disclosures:Components of CapitalFR Y-9CSchedule HC-R – Regulatory CapitalFFIEC 031Schedule RC-R – Regulatory Capital3Pg. 10FR Y-9CPg. 51-53FFIEC 031Pg. 57-59Pg. 10FR Y-9CPg. 54FFIEC 031Pg. 60-61
TableDisclosure RequirementCapital Adequacy (Table 3)Qualitative:A summary discussion of the Board-regulated institution’s(a)approach to assessing the adequacy of its capital to supportcurrent and future activities.Quantitative:(b)(c)(d)(e)Risk-weighted assets for:(1) Exposures to sovereign entities;(2) Exposures to certain supranational entities and MDBs;(3) Exposures to depository institutions, foreign banks, andcredit unions;(4) Exposures to PSEs;(5) Corporate exposures;(6) Residential mortgage exposures;(7) Statutory multifamily mortgages and pre-soldconstruction loans;(8) HVCRE loans;(9) Past due loans;(10) Other assets;(11) Cleared transactions;(12) Default fund contributions;(13) Unsettled transactions;(14) Securitization exposures; and(15) Equity exposures.Standardized market risk-weighted assets as calculated undersubpart F of this part.Common equity tier 1, tier 1 and total risk-based capitalratios:(1) For the top consolidated group; and(2) For each depository institution subsidiary.Total standardized risk-weighted assets.Capital Conservation Buffer (Table 4)Quantitative: At least quarterly, the Board-regulated institution must(a)calculate and publicly disclose the capital conservation bufferas described under § 217.11.(b)At least quarterly, the Board-regulated institution mustcalculate and publicly disclose the eligible retained income ofthe Board-regulated institution, as described under § 217.11.(c)At least quarterly, the Board-regulated institution mustcalculate and publicly disclose any limitations it has ondistributions and discretionary bonus payments resulting fromthe capital conservation buffer framework described under§ 217.11, including the maximum payout amount for thequarter.Disclosure LocationDisclosurePageForm 10-QPg. 19-21Form 10-QMD&A – Capital ManagementBasel III Regulatory Capital Disclosures:Capital AdequacyNot applicable. CSC is not subject to theMarket Risk Capital Rule.Basel III Regulatory Capital Disclosures:Capital AdequacyFR Y-9CSchedule HC-R – Regulatory CapitalFFIEC 031*Schedule RC-R Part I – Regulatory CapitalBasel III Regulatory Capital Disclosures:Capital AdequacyFR Y-9CSchedule HC-R – Regulatory CapitalFFIEC 031Schedule RC-R Part I & II– Regulatory CapitalFR Y-9CSchedule HC-R – Regulatory CapitalFFIEC 031Schedule RC-R Part I – Regulatory CapitalFR Y-9CSchedule HC-R – Regulatory CapitalFFIEC 031Schedule RC-R Part I – Regulatory CapitalBasel III Regulatory Capital Disclosures:Capital AdequacyFFIEC 031Schedule RC-R Part I – Regulatory CapitalSource Reference if applicablePg. 10Pg. 11FR Y-9CPg. 55FFIEC 031*Pg. 61Pg. 10FR Y-9CPg. 55, 67FFIEC 031Pg. 60, 67, 70-71FR Y-9CPg. 55FFIEC 031Pg. 61FR Y-9CPg. 55FFIEC 031Pg. 61Pg. 11FFIEC 031Pg. 61* The FFIEC 031 report for this disclosure requirement is applicable for all CSC-owned depository subsidiaries: Charles Schwab Bank, SSB, CharlesSchwab Premier Bank, SSB and Charles Schwab Trust Bank.4
TableDisclosure RequirementCredit Risk: General Disclosures (Table 5)Qualitative:The general qualitative disclosure requirement with respect to(a)credit risk (excluding counterparty credit risk disclosed inaccordance with Table 6), including the:(1) Policy for determining past due or delinquency status;(2) Policy for placing loans on nonaccrual;(3) Policy for returning loans to accrual status;(4) Definition of and policy for identifying impaired loans(for financial accounting purposes);(5) Description of the methodology that the Board-regulatedinstitution uses to estimate its allowance for loan andlease losses, including statistical methods used whereapplicable;(6) Policy for charging-off uncollectible amounts; and(7) Discussion of the Board-regulated institution’s creditrisk management policy.Quantitative:(b)(c)(d)(e)Disclosure LocationDisclosurePage2020 Form 10-KPg. 46-55Pg. 72-802020 Form 10-KMD&A – Risk ManagementNote 2 – Summary of Significant AccountingPoliciesTotal credit risk exposures and average credit risk exposures,after accounting offsets in accordance with GAAP, withouttaking into account the effects of credit risk mitigationtechniques (for example, collateral and netting not permittedunder GAAP), over the period categorized by major types ofcredit exposure. For example, Board-regulated institutionscould use categories similar to that used for financialstatement purposes. Such categories might include, forinstance(1) Loans, off-balance sheet commitments, and other nonderivative off-balance sheet exposures;(2) Debt securities; and(3) OTC derivatives.Geographic distribution of exposures, categorized insignificant areas by major types of credit exposure.Basel III Regulatory Capital Disclosures:Credit RiskIndustry or counterparty type distribution of exposures,categorized by major types of credit exposureBasel III Regulatory Capital Disclosures:Credit RiskBy major industry or counterparty type:(1) Amount of impaired loans for which there was a relatedallowance under GAAP;(2) Amount of impaired loans for which there was norelated allowance under GAAP;(3) Amount of loans past due 90 days and on nonaccrual;(4) Amount of loans past due 90 days and still accruing;(5) The balance in the allowance for loan and lease losses atthe end of each period, disaggregated on the basis of theBoard-regulated institution’s impairment method. Todisaggregate the information required on the basis ofimpairment methodology, an entity shall separatelydisclose the amounts based on the requirements inGAAP; and(6) Charge-offs during the period.Form 10-QNote 6 – Bank Loans and Related Allowancefor Credit LossesPg. 11-12Form 10-QMD&A – Risk ManagementNote 5 – Investment SecuritiesNote 6 – Bank Loans and Related Allowancefor Credit LossesNote 10 – Commitments and ContingenciesNote 12 – Financial Instruments Subject to OffBalance Sheet Credit RiskBasel III Regulatory Capital Disclosures:Credit Risk, Credit Exposure By GeographicConcentrations5Source Reference if applicableForm 10-QPg. 16-19Pg. 34-36Pg. 37-41Pg. 45-47Pg. 49-50Pg. 11-13Pg. 11-12Form 10-QPg. 37-41
TableDisclosure RequirementCredit Risk: General Disclosures (Table 5) – continued(f)Amount of impaired loans and, if available, the amount ofpast due loans categorized by significant geographic areasincluding, if practical, the amounts of allowances related toeach geographical area, further categorized as required byGAAP.(g)(h)Reconciliation of changes in ALLL.Disclosure LocationBasel III Regulatory Capital Disclosures:Credit Exposure By Geographic ConcentrationsForm 10-QNote 6 – Bank Loans and Related Allowancefor Credit LossesFR Y-9CSchedule HC-N – Past Due and NonaccrualLoans, Leases, and Other AssetsForm 10-QNote 6 – Bank Loans and Related Allowancefor Credit LossesFR Y-9CSchedule HI-B – Charge-Offs and Recoverieson Loans and Leases and Changes in Allowancefor Loan and Lease LossesFFIEC 031Schedule RI-B Part II. Changes in Allowancefor Loan and Lease LossesRemaining contractual maturity delineation (for example, oneyear or less) of the whole portfolio, categorized by creditexposure.Basel III Regulatory Capital Disclosures:Credit RiskFFIEC 031Schedule RC-C – Loans and FinancingReceivablesGeneral Disclosure for Counterparty Credit Risk-Related Exposures (Table 6)Qualitative:The general qualitative disclosure requirement with respect toForm 10-Q(a)OTC derivatives, eligible margin loans, and repo-styleNote 12 – Financial Instruments Subject to Offtransactions, including a discussion of:Balance Sheet Credit Risk(1) The methodology used to assign credit limits forcounterparty credit exposures;(2) Policies for securing collateral, valuing and managing2020 Form 10-Kcollateral, and establishing credit reserves;MD&A – Risk Management(3) The primary types of collateral taken; andNote 2 – Summary of Significant Accounting(4) The impact of the amount of collateral the BoardPoliciesregulated institution would have to provide given aNote 15 – Commitments and Contingenciesdeterioration in the Board-regulated institution’s ownNote 17 – Financial Instruments Subject to Offcreditworthiness.Balance Sheet Credit RiskQuantitative:(b)(c)Gross positive fair value of contracts, collateral held(including type, for example, cash, government securities),and net unsecured credit exposure.A Board-regulated institution must disclose the notional valueof credit derivative hedges purchased for counterparty creditrisk protection and the distribution of current credit exposureby exposure type.Notional amount of purchased and sold credit derivatives,segregated between use for the Board-regulated institution’sown credit portfolio and in its intermediation activities,including the distribution of the credit derivative productsused, categorized further by protection bought and soldwithin each product group.Credit Risk Mitigation (Table 7)Qualitative:The general qualitative disclosure requirement with respect to(a)credit risk mitigation, including:(1) Policies and processes for collateral valuation andmanagement;(2) A description of the main types of collateral taken bythe Board-regulated institution;(3) The main types of guarantors/credit derivativecounterparties and their creditworthiness; and(4) Not applicable. CSC does not have anycontingent payment obligations that wouldresult from a ratings downgrade.Form 10-QNote 12 – Financial Instruments Subject to OffBalance Sheet Credit RiskDisclosurePageSource Reference if applicablePg. 12-13Form 10-QPg. 37-41FR Y-9CPg. 42-46Form 10-QPg. 37-41FR Y-9CPg. 10FFIEC 031Pg. 13Pg. 11-12FFIEC 031Pg. 25Form 10-QPg. 49-502020 Form 10-KPg. 46-55Pg. 72-80Pg. 101-104Pg. 105-107Form 10-QPg. 49-50Not applicable. CSC does not hold creditderivatives.Not applicable. The Company does not transactin credit derivatives.Form 10-QNote 5 – Investment SecuritiesNote 6 – Bank Loans and Related Allowancefor Credit LossesNote 12 – Financial Instruments Subject to OffBalance Sheet Credit RiskNote 13 – Fair Values of Assets and Liabilities6Form 10-QPg. 34-36Pg. 37-41Pg. 49-50Pg. 51-54
(4)Information about (market or credit) risk concentrationswith respect to credit risk mitigation.TableDisclosure RequirementCredit Risk Mitigation (Table 7) – continuedQuantitative: For each separately disclosed credit risk portfolio, the total(b)exposure that is covered by eligible financial collateral, andafter the application of haircuts.(c)For each separately disclosed portfolio, the total exposure thatis covered by guarantees/credit derivatives and the riskweighted asset amount associated with that exposure.Securitization (Table 8)Qualitative:The general qualitative disclosure requirement with respect to(a)a securitization (including synthetic securitizations), includinga discussion of:(1) The Board-regulated institution’s objectives forsecuritizing assets, including the extent to which theseactivities transfer credit risk of the underlying exposuresaway from Board-regulated institution to other entitiesand including the type of risks assumed and retainedwith resecuritization activity;(2) The nature of the risks (e.g. liquidity risk) inherent inthe securitized assets;(3) The roles played by the Board-regulated institution inthe securitization process and an indication of the extentof the Board-regulated institution’s involvement in eachof them;(4) The processes in place to monitor changes in the creditand market risk of securitization exposures includinghow those processes differ for resecuritizationexposures;(5) The Board-regulated institution’s policy for mitigatingthe credit risk retained through securitization andresecuritization exposures; and(6) The risk-based capital approaches that the Boardregulated institution follows for its securitizationexposures including the type of securitization exposureto which each approach applies.(b)A list of:(1) The type of securitization SPEs that the Board-regulatedinstitution, as sponsor, uses to securitize third-partyexposures. The Board-regulated institution must indicatewhether it has exposure to these SPEs, either on- or offbalance sheet; and(2) Affiliated entities:(i) That the Board-regulated institution manages oradvises; and(ii) That invest either in the securitization exposuresthat the Board-regulated institution has securitizedor in securitization SPEs that the Board-regulatedinstitution sponsors.2020 Form 10-KPg. 46-55Pg. 72-802020 Form 10-KMD&A – Risk ManagementNote 2 – Summary of Significant AccountingPoliciesDisclosure LocationDisclosurePageForm 10-QPg. 49-50Form 10-QNote 12 – Financial Instruments Subject to OffBalance Sheet Credit RiskNot applicable. CSC does not hold creditderivatives.Basel III Regulatory Capital Disclosures:SecuritizationsNot applicable. CSC does not securitize assets.7Source Reference if applicablePg. 13-14
(c)Summary of the Board-regulated institution’s accountingpolicies for securitization activities, including:(1) Whether the transactions are treated as sales orfinancings;(2) Recognition of gain-on-sale;(3) Methods and key assumptions applied in valuingretained or purchased interests;(4) Changes in methods and key assumptions from theprevious period for valuing retained interests and impactof the changes;(5) Treatment of synthetic securitizations;(6) How exposures intended to be securitized are valuedand whether they are recorded under subpart D of thispart; and(7) Policies for recognizing liabilities on the balance sheetfor arrangements that could require the Board-regulatedinstitution to provide financial support for securitizedassets.TableDisclosure RequirementSecuritization (Table 8) – continued(d)An explanation of significant changes to any quantitativeinformation since the last reporting period.Quantitative:(e)Not applicable. CSC does not securitize assets.Disclosure LocationNot applicable. CSC does not securitize assets.(f)For exposures securitized by Board-regulated institution insecuritizations that meet the operational criteria in § 217.41:(1) Amount of securitized assets that are impaired/past duecategorized by exposure type; and(2) Losses recognized by Board-regulated institution duringthe current period categorized by exposure type.Not applicable. CSC does not securitize assets.(g)The total amount of outstanding exposures intended to besecuritized categorized by exposure type.Not applicable. CSC does not securitize assets.(h)Aggregate amount of:(1) On-balance sheet securitization exposures retained orpurchased categorized by exposure type; and(2) Off-balance sheet securitization exposures categorizedby exposure type.Basel III Regulatory Capital Disclosures:Securitizations(1)(2)Aggregate amount of securitization exposures retainedor purchased and the associated capital requirements forthese exposures, categorized between securitization andresecuritization exposures, further categorized into ameaningful number of risk weight bands and by riskbased capital approach (e.g., SSFA); andExposures that have been deducted entirely from tier 1capital, CEIOs deducted from total capital (as describedin § 217.42(a) (1), and other exposures deducted fromtotal capital should be disclosed separately by exposuretype.Source Reference if applicableNot applicable. CSC does not securitize assets.The total outstanding exposures securitized by the Boardregulated institution in securitizations that meet theoperational criteria provided in § 217.41 (categorized intotraditional and synthetic securitizations), by exposure type,separately for securitizations of third-party exposures forwhich the bank acts only as sponsor.(i)DisclosurePagePg. 13-14FR Y-9CSchedule HC-R – Regulatory CapitalFR Y-9CPg. 63FFIEC 031Schedule RC-R Part II – Regulatory CapitalBasel III Regulatory Capital Disclosures:SecuritizationsFFIEC 031Pg. 66(j)Summary of current year’s securitization activity, includingthe amount of exposures securitized (by exposure type), andrecognized gain or loss on sale by exposure type.Not applicable. CSC does not securitize assets.(k)Aggregate amount of resecuritization exposures retained orpurchased categorized according to:(1) Exposures to which credit risk mitigation is applied andthose not applied; and(2) Exposures to guarantors categorized according toguarantor creditworthiness categories or guarantorname.Not applicable. CSC does
Basel III Regulatory Capital Disclosures: Capital Adequacy Pg. 10 (c) Standardized market risk-weighted assets as calculated under subpart F of this part. Not applicable. CSC is not subject to the Market Risk Capital Rule. (d) Common equity tier 1, tier 1 and total risk-based capital ratios: (1) For the top consolidated group; and
The Basel III international regulatory framework, which was produced in 2010 by the Basel . Highlights of the Final Rule Implementing Basel III and Various Dodd-Frank . 0129_capital_primer_elliott.pdf. 8 The name, Basel Accord, comes from Basel, Switzerland, the home of the Bank for International Settlements (BIS).
Basel III beyond the capital surcharges, may differ from the findings of a comprehensive analysis of Basel III. JEL Codes: G01, G18, G21. 1. Introduction The Basel Committee on Banking Supervision (BCBS, the Basel Committee, or Basel) has developed a methodology for identifying global systemically important banks (G-SIBs) and assessing a higher
Committee on Banking Supervision’s Basel III capital framework (the “Basel III final rule”). The Compa ny became subject to the U.S. Basel III final rule on January 1, 2014. Certain requirements in the U.S. Basel III final rule, including the new minimum risk-based capital ratios, regulatory capital deductions and adjustments, and the U.S.
The Basel III framework . Executive summary This document comprises of the Group's capital and risk management disclosures as at 30 June 2020. The disclosures in this document are in addition to the disclosures set out in the interim condensed consolidated financial statements presented in accordance with Interim Financial .
In July 2013, the U.S. banking regulators issued a final rule to implement many aspects of Basel III (“U.S. Basel III”). Although the Company and its U.S. Subsidiary Banks became subject to U.S. Basel III beginning on January 1, 2014, certain requirements of U.S. Basel III will be phased in over several years.
to as Basel 2.5. Basel Pillar 3 III The Group adopted the Basel DisclosuresIII measurement and monitoring of regulatory capital effective from 1 January 2013. In December 2010, the Basel Committee on Banking Supervision (BCBS) published a discussion paper on banking reforms to address issues which led to the Global Financial
Basel III - Pillar 3 Disclosures 31 December 2018 3 EXECUTIVE SUMMARY As a bank, incorporated in the Kingdom of Bahrain, United Gulf Bank B.S.C. (c) ("UG" or "the ank") has complied with the Basel III Capital Adequacy Framework effective 1 January 2015. This is in
Petitioner-Appellee Albert Woodfox once again before this Courtis in connection with his federal habeas petition.The district c ourt had originally granted Woodfox federal habeas relief on the basis of ineffective assistance of counsel, but weheld that the district court erred in light of the deferential review affordedto state courts under the Antiterrorism and Effective Death Penalty Act of .
